Drugmaker Abbott India posts Q4 profit rise on higher sales
BENGALURU (Reuters) – Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government pricing caps on certain medicines. The company, which makes the popular antacid medicine Digene, …